222 related articles for article (PubMed ID: 31088837)
1. Magnetic Resonance Imaging Is More Sensitive Than PET for Detecting Treatment-Induced Cell Death-Dependent Changes in Glycolysis.
Hesketh RL; Wang J; Wright AJ; Lewis DY; Denton AE; Grenfell R; Miller JL; Bielik R; Gehrung M; Fala M; Ros S; Xie B; Hu DE; Brindle KM
Cancer Res; 2019 Jul; 79(14):3557-3569. PubMed ID: 31088837
[TBL] [Abstract][Full Text] [Related]
2. Combined hyperpolarized
Hansen AE; Gutte H; Holst P; Johannesen HH; Rahbek S; Clemmensen AE; Larsen MME; Schøier C; Ardenkjaer-Larsen J; Klausen TL; Kristensen AT; Kjaer A
Eur J Radiol; 2018 Jun; 103():6-12. PubMed ID: 29803387
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous Hyperpolarized 13C-Pyruvate MRI and 18F-FDG PET (HyperPET) in 10 Dogs with Cancer.
Gutte H; Hansen AE; Larsen MM; Rahbek S; Henriksen ST; Johannesen HH; Ardenkjaer-Larsen J; Kristensen AT; Højgaard L; Kjær A
J Nucl Med; 2015 Nov; 56(11):1786-92. PubMed ID: 26338899
[TBL] [Abstract][Full Text] [Related]
4.
Liu H; Sun H; Zhang B; Liu S; Deng S; Weng Z; Zuo B; Yang J; He Y
Breast Cancer; 2020 May; 27(3):372-380. PubMed ID: 31781983
[TBL] [Abstract][Full Text] [Related]
5. Multimodal assessment of in vivo metabolism with hyperpolarized [1-13C]MR spectroscopy and 18F-FDG PET imaging in hepatocellular carcinoma tumor-bearing rats.
Menzel MI; Farrell EV; Janich MA; Khegai O; Wiesinger F; Nekolla S; Otto AM; Haase A; Schulte RF; Schwaiger M
J Nucl Med; 2013 Jul; 54(7):1113-9. PubMed ID: 23596002
[TBL] [Abstract][Full Text] [Related]
6. A comparison between radiolabeled fluorodeoxyglucose uptake and hyperpolarized (13)C-labeled pyruvate utilization as methods for detecting tumor response to treatment.
Witney TH; Kettunen MI; Day SE; Hu DE; Neves AA; Gallagher FA; Fulton SM; Brindle KM
Neoplasia; 2009 Jun; 11(6):574-82, 1 p following 582. PubMed ID: 19484146
[TBL] [Abstract][Full Text] [Related]
7. Pyruvate-lactate exchange and glucose uptake in human prostate cancer cell models. A study in xenografts and suspensions by hyperpolarized [1-
van Heijster FHA; Heskamp S; Breukels V; Veltien A; Franssen GM; Jansen KCFJ; Boerman OC; Schalken JA; Scheenen TWJ; Heerschap A
NMR Biomed; 2020 Oct; 33(10):e4362. PubMed ID: 32662543
[TBL] [Abstract][Full Text] [Related]
8. Multimodality In Vivo Imaging of Perfusion and Glycolysis in a Rat Model of C6 Glioma.
Qi Q; Fox MS; Lim H; Bartha R; Scholl TJ; Hoffman L; Lee TY; Thiessen JD
Mol Imaging Biol; 2021 Aug; 23(4):516-526. PubMed ID: 33534038
[TBL] [Abstract][Full Text] [Related]
9. GlucoCEST MRI for the Evaluation Response to Chemotherapeutic and Metabolic Treatments in a Murine Triple-Negative Breast Cancer: A Comparison with[
Capozza M; Anemone A; Dhakan C; Della Peruta M; Bracesco M; Zullino S; Villano D; Terreno E; Longo DL; Aime S
Mol Imaging Biol; 2022 Feb; 24(1):126-134. PubMed ID: 34383241
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive
Henry KE; Dilling TR; Abdel-Atti D; Edwards KJ; Evans MJ; Lewis JS
J Nucl Med; 2018 Jan; 59(1):51-57. PubMed ID: 28848040
[TBL] [Abstract][Full Text] [Related]
11. Hyperpolarized [1-
Esfahani SA; Callahan C; Rotile NJ; Heidari P; Mahmood U; Caravan PD; Grant AK; Yen YF
Mol Imaging Biol; 2022 Oct; 24(5):769-779. PubMed ID: 35467249
[TBL] [Abstract][Full Text] [Related]
12. Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models.
Neveu MA; De Preter G; Joudiou N; Bol A; Brender JR; Saito K; Kishimoto S; Grégoire V; Jordan BF; Krishna MC; Feron O; Gallez B
Oncotarget; 2016 Dec; 7(49):81741-81749. PubMed ID: 28082726
[TBL] [Abstract][Full Text] [Related]
13. In Vivo Assessment of Ovarian Tumor Response to Tyrosine Kinase Inhibitor Pazopanib by Using Hyperpolarized
Ravoori MK; Singh SP; Lee J; Bankson JA; Kundra V
Radiology; 2017 Dec; 285(3):830-838. PubMed ID: 28707963
[TBL] [Abstract][Full Text] [Related]
14. Molecular Imaging of the Tumor Microenvironment Reveals the Relationship between Tumor Oxygenation, Glucose Uptake, and Glycolysis in Pancreatic Ductal Adenocarcinoma.
Yamamoto K; Brender JR; Seki T; Kishimoto S; Oshima N; Choudhuri R; Adler SS; Jagoda EM; Saito K; Devasahayam N; Choyke PL; Mitchell JB; Krishna MC
Cancer Res; 2020 Jun; 80(11):2087-2093. PubMed ID: 32245793
[TBL] [Abstract][Full Text] [Related]
15. Monitoring response to gefitinib in nude mouse tumor xenografts by (18)F-FDG microPET-CT: correlation between (18)F-FDG uptake and pathological response.
Zhou LN; Wu N; Liang Y; Gao K; Li XY; Zhang LF
World J Surg Oncol; 2015 Mar; 13():111. PubMed ID: 25888731
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous characterization of tumor cellularity and the Warburg effect with PET, MRI and hyperpolarized
Hundshammer C; Braeuer M; Müller CA; Hansen AE; Schillmaier M; Düwel S; Feuerecker B; Glaser SJ; Haase A; Weichert W; Steiger K; Cabello J; Schilling F; Hövener JB; Kjær A; Nekolla SG; Schwaiger M
Theranostics; 2018; 8(17):4765-4780. PubMed ID: 30279736
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive Classification of Human Triple Negative Breast Cancer by PET Imaging with GRP78-Targeted Molecular Probe [
Zhao H; Meng H; Wen J; Wang C; Liu J; Huang G
Mol Imaging Biol; 2020 Jun; 22(3):772-779. PubMed ID: 31452065
[TBL] [Abstract][Full Text] [Related]
18. Early prediction of triple negative breast cancer response to cisplatin treatment using diffusion-weighted MRI and
Nguyen-Thu H; Hanaoka H; Nakajima T; Yamaguchi A; Nguyen-Cong T; Kartamihardja AAP; Tsushima Y
Breast Cancer; 2018 May; 25(3):334-342. PubMed ID: 29357023
[TBL] [Abstract][Full Text] [Related]
19. Dynamic (18)F-FDG-PET for monitoring treatment effect following anti-angiogenic therapy in triple-negative breast cancer xenografts.
Kristian A; Revheim ME; Qu H; Mælandsmo GM; Engebråten O; Seierstad T; Malinen E
Acta Oncol; 2013 Oct; 52(7):1566-72. PubMed ID: 23984812
[TBL] [Abstract][Full Text] [Related]
20. Lactic Acid Accumulation in the Tumor Microenvironment Suppresses
Türkcan S; Kiru L; Naczynski DJ; Sasportas LS; Pratx G
Cancer Res; 2019 Jan; 79(2):410-419. PubMed ID: 30510121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
